A New Approach page top left image

LDDN Postdoctoral Sabbatical Program In Drug Discovery Awardees

The Harvard NeuroDiscovery Center's Laboratory for Drug Discovery in Neurodegeneration is pleased to announce the annual awardees for the Postdoctoral Sabbatical Program:

AY09 - NCDDN Fellows

Dimitri Krainc (Harvard Medical School/Brigham and Women's Hospital) — PGC-1alpha Transcriptional Assay

David Ron (New York University) — Inhibition of Sulfhydryl Oxidases to Control Oxidative Stress

Haining Zhu (University of Kentucky) — Abrogating interaction between Mutant SOD I and Dynein: A Novel ALS Therapeutic Strategy

Colin Combs (University of North Dakota) — Inhibition of lyn kinase to attenuate oligomer-stimulated microglial activation in Alzheimer's disease

Carmela Abraham (Boston University) — Screen for small compounds the inhibit APP dimerization and Abeta generation

AY08 - NCDDN Fellows

Jeremy Hwang, Mentor Tae-Wan Kim (Columbia University) — Modulators of BACE1-mediated APP cleavage

Kent Matlack, Mentor Susan Lindquist (Whitehead Institute) — Yeast drug discovery platforms for protein misfolding

Yang Zhang, Mentor Paul Lombroso (Yale University) — Screening for Inhibitors for STEP

Heechul Kim, Mentor Hoon Ryu (Boston University) — Targeting of BRCA1 in Neuronal DNA Damage Response

Shibu Poulose, Mentor Zhenyu Yue (Mount Sinai School of Medicine) — Inhibitors of kinase/GTPase activities of the brain Lrrk2 

AY07 - NCDDN Fellows

Sang-Jun Jeon, Mentor Albert Edge (Massachusetts Eye and Ear Infirmary) — A Screen for Atoh1 Activation

Melissa Sarantos, Mentor Robert Hughes (Buck Institute) — Specific Translational Inhibition of Mutant Htt

Craig Colton, Mentor Chien-Liang (Ohio State University) — Stimulation of glial Glutamate transporter EAAT2 expression

Wensheng Lin, Mentor Brian Popko (University of Chicago) — Activators of the PERK Pathway

Segal, Mentor Benjamin Wolozin (Boston University) — Identification of Functional Inhibitors of LRRK2

AY06 - NCDDN Fellows

Kathleen Seyb, PhD, Mentor Mary Michaelis, PhD (University of Kansas) - Inhibitors of Abeta induced calpain activation

Tommy Gainer, PhD, Mentor Donald Lo (Duke University) — Inhibitors of EphB3 kinase

Imelda Pepivani, PhD, Mentor Michael Schlossmacher (Brigham and Women's Hospital) — Modulators of the Expression of the Parkin Gene

Carl Sunshine, PhD, Mentor Steve Finkbeiner (University of California, San Francisco) — Modulation of Akt kinase

Luisa Quinti, PhD, Mentor Steve Finkbeiner (University of California, San Francisco) — Inhibition of toxic conformation isomerization of polyQ 

AY05

Greg Korbel, PhD, Mentor Hidde L. Ploegh, PhD (Harvard Medical School) — High-throughput screening for neuroprotective small molecule modulation in Huntington's disease and chemistry-based target identification

Anatolii Kabakov, PhD, Mentor Paul Rosenberg, MD, PhD (Children's Hospital) — Discovery of modulators of glutamate transport in the central nervous system

Ana George, PhD, Mentor Richard E. Fine, PhD (Boston University) — Library screen for drugs that increase IDE in cerebrovasculature

AY04

Hanspeter Waldner, PhD (Brigham and Women's Hospital) — Identifying drug-like molecules that modulate Th1/Th2 cytokine production in myelin-reactive T cells

AY03

Jae Suk Ahn, PhD, Mentor Kenneth S. Kosik, MD (Brigham and Women's Hospital) — Development of high-throughtput assays to screen for inhibitors of tau

Pancham Bakshi, PhD, Mentor Michael Wolfe, PhD (Brigham and Women's Hospital) — A high-throughput screen to identify modulators of amyloid beta precursor protein processing

Xiaoyan Sun, MD, PhD, Mentor Jie Shen, PhD (Brigham and Women's Hospital) — Screen compounds that are differentially toxic to parkin knockout neurons

Tasneem Zahir, PhD, Mentor Michael Young, PhD (Schepens Eye Research Institute) — Identification of small molecules that promote differentiation of stem cells

Melissa Joy Nicholson, PhD, Mentor Kai Wucherpfennig, MD, PhD (Dana-Farber Cancer Institute/Harvard Medical School) — Inhibition of antigen presentation in multiple sclerosis 

AY02

David Wilson, PhD, Mentor Clifford B. Saper, MD, PhD (Beth Israel Deaconess Medical Center) — Polymerization of full length tau

Craig Justman, PhD, Mentor Peter Lansbury, PhD (Brigham and Women's Hospital) — Oligomerization of synuclein

June-Young Park, PhD, Mentor Peter Lansbury, PhD (Brigham and Women's Hospital) — UCH-L1 expression

Hilal Lashuel, PhD, Mentor Peter Lansbury, PhD (Brigham and Women's Hospital) — UCH-L1 activity

Sunny Sarang, PhD, Mentor Steven R. Gullans, PhD (Brigham and Women's Hospital) — alpha-Synuclein expression

Jin Wang, PhD, Mentor James F. Gusella, PhD (Massachusetts General Hospital) — PolyGlu aggregation

Pierre-Francois Pradat, PhD, Mentor Robert H. Brown, MD, PhD (Massachusetts General Hospital) — SOD activity